收入增长 - 公司收入增加14%，主要由于XpresTest CDC合同增加和收购Naples Wax[172,173] - 总收入增加2,770万美元或18%，主要由于XpresTest CDC合同增加和新增Naples Wax[191] 成本下降 - 成本下降11%，主要由于3家XpresSpa门店关闭[174,175] - 销售成本下降1,262万美元或9%，主要由于2023年关闭了3家XpresSpa门店[194] 折旧和摊销费用下降 - 折旧和摊销费用下降62%，主要由于2023年关闭门店导致租赁改良折旧减少[176,177] - 折旧和摊销费用下降727万美元或62%，主要由于2023年关闭的门店资产减值和处置[196] 费用优化 - 一般管理费用下降3%，主要由于优化成本结构[180,181,182] - 一般和管理费用下降2,125万美元或29%，主要由于精简现有业务和优化成本结构[199] 人员精减 - 工资和福利费用下降22%，主要由于裁员[183,184] - 工资和福利费用下降510万美元或12%，主要由于人员精减[201] 利息收入下降 - 获得利息收入105美元，较上年同期减少8美元[187,188] 资产处置损失 - 处置资产损失增加653万美元，主要由于关闭盐湖城国际机场Treat门店和奥兰多一家XpresSpa门店[197] 流动性 - 现金及现金等价物为5,418万美元，流动资产总额为23,135万美元，流动负债总额为10,440万美元，流动资金盈余为12,695万美元[206] - 公司认为有足够的流动性支持未来12个月的运营[207] 股票回购 - 公司于2021年8月启动了750,000股的股票回购计划，并于2022年5月增加500,000股并延长至2023年9月15日[208]

文章核心观点 - XWELL公司宣布CPC Pain & Wellness SPV, LLC决定撤回针对公司2024年股东大会的代理权争夺和相关诉讼 [1][2] - 公司董事长表示公司将专注于执行战略计划,为股东创造持久的长期价值 [2] - XWELL是一家全球领先的健康和福祉控股公司,旗下拥有多个品牌 [3][4] 公司概况 - XWELL是一家在纳斯达克上市的公司,是一家全球领先的健康和福祉控股公司 [3] - 公司旗下拥有多个品牌,包括XpresSpa、Treat、Naples Wax Center、XpresCheck和HyperPointe [3][4] - XpresSpa是一家在全球16个机场拥有33家门店的健康服务和相关产品零售商 [4] - Naples Wax Center是一家拥有3家门店的高端护肤品牌 [4] - XpresCheck是一家与CDC和Concentric by Ginkgo合作,在机场进行新冠病毒变异株和其他病原体监测的诊断检测服务提供商 [4] - HyperPointe是一家为全球医疗行业提供数字医疗和数据分析服务的公司 [4]

NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced the closing of its previously announced registered direct offering priced at a premium to market for the issuance and sale of an aggregate of 652,705 shares of its common stock, par value $0.01 per share, at a purchase price of $2.18 per share. The gross proceeds to the Company from the offering were approximately $1.4 million, before ded ...

The sole focus of CPC’s position and lawsuit against XWELL’s entrenched Board of Directors (the “Entrenched Directors”) is to provide shareholders with an opportunity to elect a competing slate of directors to XWELL’s existing Board at the next annual shareholder meeting.Under the leadership of the incumbent Board, led by Chairman Bruce Bernstein, XWELL has reported a combined net operating loss of $207.3 million from 2018 through 2023.Since February 2016, XWELL’s common stock has declined in value by appro ...

Exhibit 99.1 XWELL, Inc. Reports First Quarter 2024 Results NEW YORK, May 15, 2024 -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2024. Recent Highlights: · XWELL delivered 2024 first quarter revenue growth of approximately 24% from the 2023 first quarter. · The Company has reduced its cost structure, simplified its processes, and has maintained continued momentum on its path to p ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number: 001-34785 XWELL, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-4988129 (State or o ...

XWELL, Inc. (NASDAQ:XWEL) Q4 2023 Earnings Conference Call April 16, 2024 5:00 PM ET Company Participants Suzanne Scrabis - CFO Scott Milford - CEO Operator Hello, and welcome to XWELL's Fiscal Year 2023 Earnings Results Conference Call. During today's presentation, all parties will be in a listen-only mode. [Operator Instructions] As a reminder, this conference call is being recorded on April 16, 2024. I would now like to turn the conference over to Suzanne Scrabis, Chief Financial Officer for XWELL. Pleas ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number 001-34785 XWELL, Inc. (Exact name of registrant as specified in its charter) Delaware 20-4988129 (State or othe ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number: 001-34785 XWELL, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-4988129 (State ...

XWELL, Inc. (NASDAQ:XWEL) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Suzanne Scrabis - CFO Scott Milford - CEO Operator Greetings. Welcome to XWELL's Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded on August 14, 2023. I would now like to turn the conference over to Suzanne Scrabis, Chief Financial Officer for XWELL. Please go ahead. Suzanne Scrabis Good day, everyone. Welcome to XWELL's conference cal ...